Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF
US ˙ ARCA

SecurityPBE / Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF
InstitutionMcIlrath & Eck, LLC
Latest Disclosed Ownership205 shares
Latest Disclosed Value $ 16,232
McIlrath & Eck, LLC ownership in PBE / Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF

On May 19, 2026 - McIlrath & Eck, LLC filed a 13F-HR form disclosing ownership of 205 shares of Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF (US:PBE) valued at $16,232 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 205 shares of Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $16,921 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-19 2026-03-31 13F INVESCO EXCHANGE-TRADED FD TR BIOTECHNOLOGY & GENOME ETF EXCHANGE TRADED FUND 46137V787 205 0 0.00 16 0.00 0.0012
2026-02-03 2025-12-31 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 17 14.29 0.0016
2025-10-22 2025-09-30 13F INVESCO EXCHANGE TRADED FD T IOTECHNOLOGY 46137V787 205 0 0.00 14 7.69 0.0015
2025-08-14 2025-06-30 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 13 0.00 0.0015
2025-05-16 2025-03-31 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 13 0.00 0.0016
2025-02-18 2024-12-31 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 14 -7.14 0.0017
2024-11-19 2024-09-30 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 14 7.69 0.0018
2024-08-14 2024-06-30 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 13 0.00 0.0020
2024-05-10 2024-03-31 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 13 0.00 0.0021
2024-02-06 2023-12-31 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 13 18.18 0.0024
2023-11-16 2023-09-30 13F INVESCO EXCHANGE TRADED FD T BIOTECHNOLOGY 46137V787 205 0 0.00 12 -8.33 0.0024
2023-08-07 2023-06-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 13 0.00 0.0026
2023-05-09 2023-03-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 13 -7.69 0.0030
2023-02-15 2022-12-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 13 8.33 0.0034
2022-10-18 2022-09-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 12 0.00 0.0033
2022-07-29 2022-06-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 12 -7.69 0.0037
2022-05-11 2022-03-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 13 -13.33 0.0038
2022-02-08 2021-12-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 15 0.00 0.0041
2021-11-12 2021-09-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 15 -6.25 0.0045
2021-08-09 2021-06-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 16 6.67 0.0049
2021-05-12 2021-03-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 15 7.14 0.0052
2021-02-05 2020-12-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 14 16.67 0.0052
2020-11-13 2020-09-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 12 0.00 0.0051
2020-08-04 2020-06-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 12 20.00 0.0056
2020-05-14 2020-03-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 10 -9.09 0.0056
2020-02-11 2019-12-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 11 10.00 0.0053
2019-11-05 2019-09-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 10 -9.09 0.0053
2019-08-08 2019-06-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 11 0.00 0.0061
2019-05-07 2019-03-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 11 10.00 0.0061
2019-05-07 2018-12-31 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 10 -16.67 0.0064
2018-11-13 2018-09-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 0 0.00 12 9.09 0.0069
2018-08-06 2018-06-30 13F INVESCO EXCHANGE TRADED FD T DYNMC BIOTECH 46137V787 205 205 11 0.0067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.